Moneycontrol
HomeNewsIndiaCOVID-19: ICMR allows home testing through rapid antigen test kit, here's all you need to know

COVID-19: ICMR allows home testing through rapid antigen test kit, here's all you need to know

ICMR has approved Pune-based Mylab Discovery Solutions' kit making it easy for people to test themselves for COVID at home.

May 20, 2021 / 14:28 IST
Story continues below Advertisement
As of now, ICMR has approved Pune-based Mylab Discovery Solutions' CoviSelfTM (PathoCatch) COVID-19 OTC Antigen LF device, which is a nasal swab RAT test.

The Indian Council of Medical Research (ICMR) on May 19 issued an advisory for COVID-19 home testing using rapid antigen Tests (RATs). Home testing has been advised for symptomatic suspected COVID-19 patients and also for those in immediate contact with confirmed coronavirus cases.

The new advisory comes almost two weeks after the ICMR issued new guidelines for RT-PCR testingĀ for healthy individuals undertaking inter-state domestic travel.

Story continues below Advertisement

Here is all you need to know about the home-testing guidelines:

- Home testing by RAT is advised only in symptomatic individuals and immediate contacts of laboratory-confirmed positive cases. Indiscriminate testing is not advised.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show